Management of Consecutive Exotropia

Patients with consecutive exotropia will be managed by medial rectus muscle advancement +/- resection or medial rectus muscle advancement +/- lateral rectus recession

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Strabismus Concomitant Squint Cranial Nerve Diseases Divergent Strabismus Exotropia Eye Diseases Nervous System Diseases Ocular Motility Disorders

Age range

8 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine

Minya, Minya Governorate, 61111, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with consecutive exotropia.
Eight years old or more.
Cooperative patients.

Exclusion criteria

Adduction deficit.
Mental disability.

Treatment and study plan

Strabismus surgery

Procedure

Strengthening of medial rectus muscle or strengthening of medial rectus muscle with weakening of the lateral rectus muscle

Primary outcomes

Percentage of patients with satisfactory postoperative alignment

Time frame: 6 months

Efficacy of each surgical procedure and its further effect using prism cover test to access postoperative alignment of the eye

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Management of Consecutive Exotropia and Its Effect on Ocular Motility

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jul 14, 2021
Registry last updated: Jan 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed